There’s no denying Andrew Witty’s influence over the future of health care: Not only is he the head of the biggest insurer in the U.S., but he has also presided over the growth of UnitedHealth into one of the country’s largest providers of outpatient care, employing or affiliated with almost 10% of all U.S. physicians. That means Witty is often in the spotlight, whether navigating the controversy from STAT’s investigative reporting on a United subsidiary’s use of algorithms to deny or cut off care to Medicare patients or making predictions about how seniors’ rising use of medical care could impact future earnings for United and other insurers. He also recently commented on the timely issue of how the high cost of GLP-1 drugs is limiting access. “We’re struggling, and frankly our clients are struggling, with the list prices which have been demanded of these products in the U.S.,” he said.
More in Business
Business
Greg Adams
Chair and CEO, Kaiser Permanente
Business
Behzad Aghazadeh
Managing partner and portfolio manager, Avoro Capital
Business
Kristina Burow
Managing director, ARCH Venture Partners
Business
Susan Galbraith
Executive vice president of oncology research and development, AstraZeneca
Business
Matt Gline
CEO, Roivant Sciences
Business
Reshma Kewalramani
CEO and president, Vertex Pharmaceuticals
Business
Lotte Knudsen
Chief scientific adviser, Novo Nordisk
Business
Peter Lee
Corporate vice president, Microsoft Research & Incubations
Business
Ted Love
Chair, BIO
Business
Karen S. Lynch
CVS Health president and CEO
Business
Joshua Miele
Principal accessibility researcher, Amazon
Business
Umer Raffat
Senior managing director, Evercore ISI
Business
Daniel Skovronsky
Chief scientific officer, Eli Lilly and Company
Business
Tim Van Hauwermeiren
CEO, Argenx
Business
Chris Viehbacher
President and chief executive officer, Biogen
Fifty influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech
View the List